Chemotherapeutic evaluation of a synthetic tubulysin analogue-dendrimer conjugate in c26 tumor bearing mice.
University of California, Berkeley, 94720-1460, USA.
William C
WC
Floyd
Gopal K
GK
Datta
Shinichi
S
Imamura
Heidi M
HM
Kieler-Ferguson
Katherine
K
Jerger
Andrew W
AW
Patterson
Megan E
ME
Fox
Francis C
FC
Szoka
Jean M J
JM
Fréchet
Jonathan A
JA
Ellman
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000138:chemical synthesis / Q000378:metabolism; D003110:Colonic Neoplasms / Q000188:drug therapy; D015179:Colorectal Neoplasms / Q000188:drug therapy; D050091:Dendrimers / Q000008:administration & dosage / Q000138:chemical synthesis / Q000378:metabolism; D004195:Disease Models, Animal; D004337:Drug Carriers / Q000008:administration & dosage / Q000138:chemical synthesis / Q000378:metabolism; D004353:Drug Evaluation, Preclinical; D011992:Endosomes / Q000378:metabolism; D005260:Female; D051379:Mice; D008807:Mice, Inbred BALB C; D009842:Oligopeptides / Q000008:administration & dosage / Q000138:chemical synthesis / Q000378:metabolism; D012995:Solubility
D000970:Antineoplastic Agents; D050091:Dendrimers; D004337:Drug Carriers; D009842:Oligopeptides; C502386:tubulysin D